bpc-157 tight junction intestinal permeability study Frontiers The Stable Gastric Pentadecapeptide BPC

K., Malmstrm, J., Hjlys-Larsen, K

Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options

do not shake or vortex

If you have pernicious anaemia the injections are needed for life

If you're not seeing improvement after following your protocol, that's important information not a failure